ALFA FinderBSE filing, NSE: BOSCHLTD. Summary written from the filing by ALFA Finder's alert engine.
Bosch Ltd: key numbers
- Share price
- ₹50,455.00
- Market cap
- ₹1,48,823 Cr
- Revenue (annual)
- ₹20,035 Cr
- Net profit (annual)
- ₹2,773 Cr
- P/E (TTM)
- 56.2×Sector 32.5×
- Promoter holding
- 70.54%+0.00% QoQ
- FII holding
- 7.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bosch Ltd
All →Bosch Earnings Call Transcript: Key Takeaways
Consolidated revenue rose 28.2% and EBITA 23.2%, with margins slightly squeezed by aluminium and INR-EUR. PAT grew 18.5%, helped by a ₹130 Cr exceptional credit. Management guides a modest H2.
Bosch Bonus Issue
Bosch Limited's board recommended a 3:1 bonus issue on 6 November 2026, funded from free reserves. Shares are expected to be credited by 6 January 2027, subject to approvals.
- Execution
- Within 2 months from 06-11-2026 (credit by 06-01-2027)
Bosch Q2 FY27 Results: Net Profit ₹840.5 Cr, Up 18.6% YoY
Bosch Ltd reported revenue from operations of ₹7,655 Cr (+28.2% YoY) and net profit of ₹840.5 Cr (+18.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹840.5 Cr · +18.6% YoY
Bosch Bonus Issue
Bosch will consider a stock split and bonus issue at its November 6, 2026 board meeting. Both remain subject to shareholder approval.
Bosch Other Announcement
Bosch Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026, as per SEBI disclosure requirements.
Bosch Board Meeting Date
Bosch Limited has scheduled a board meeting for November 6, 2026. The board will consider and approve un-audited financial results for the quarter ending September 30, 2026.
Other merger & restructuring announcements
All →Zydus Lifesciences Merger & Restructuring Worth ₹9.38 Cr
Zydus Lifesciences completed its ₹9.38 Crore 50% subscription in JV Zydus Sunshine Lifesciences. The transaction with Sunshine Healthcare Lanka was fully executed on November 11, 2026.
- Value
- ₹9.38 Cr
Zydus Lifesciences Merger & Restructuring
Zydus completed its subscription for 50% of Zydus Sunshine, making it a 50:50 joint venture with Sunshine Healthcare Lanka. Completed November 11, 2026.
Spacenet Enterprises India Merger & Restructuring Worth ₹2.6 Cr
Spacenet sold 40,00,005 String Metaverse shares on 11 November 2026 at ₹6.49 each. Gross consideration of about ₹2.60 Crore is disclosed as material.
- Value
- ₹2.60 Cr
Abans Financial Services Merger & Restructuring Worth ₹1.2 Cr
Abans Financial Services approved incorporating a Hong Kong subsidiary for bullion and securities trading. The cash consideration is Rs 1.20 Crore.
- Value
- ₹1.20 Cr
Adani Enterprises Merger & Restructuring Worth ₹0.94 Cr
Adani Enterprises reported incorporation of Adani Rovuma Chemicals Limited in UAE on November 10, 2026, via Adani Global Limited. Cash consideration of Rs. 0.94 Crore was stated.
- Value
- ₹0.94 Cr
Adani Enterprises Merger & Restructuring
Adani Enterprises' subsidiary Adani Global incorporated Adani Rovuma Chemicals Limited in UAE on November 10, 2026. It is a step-down subsidiary with USD 100,000 paid-up capital.